Biodesix Inc (BDSX) reports a 45% revenue increase in 2024, with strategic moves to expand market access and improve ...
33m
ADMA Biologics Inc (ADMA) reports a 65% revenue surge and outlines future growth strategies amid regulatory and operational ...
33m
Quantum-Si Inc (QSI) reports a 183% annual revenue increase and strategic milestones, despite challenges in market penetration and funding uncertainties.
33m
ThredUp Inc (TDUP) reports a 9.5% revenue increase and AI-driven enhancements, despite a drop in active buyers and challenges in the consumer environment.
Mersana Therapeutics Inc (MRSN) reports promising clinical progress and improved financial metrics, positioning itself ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback